INCB123667 Clinical Trials

3 actively recruiting trials across 3 locations

▲ +1 trial since June 2026

Pipeline

Phase 1: 1Phase 2: 1Phase 3: 1

Top Sponsors

Incyte Corporation3

Indications

Cancer3
Ovarian Cancer2
Hepatic Insufficiency1
Liver Disease1
Liver Diseases1

Mobile, Alabama1 trial

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Usa Health Mitchell Cancer Institute

Phase 2

Anchorage, Alaska1 trial

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Alaska Womens Cancer Care Akwcc

Phase 3

Chandler, Arizona1 trial

A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment

Arizona Clinical Trials - the Institute For Liver Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.